1. Home
  2. CTGO vs MNPR Comparison

CTGO vs MNPR Comparison

Compare CTGO & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contango ORE Inc.

CTGO

Contango ORE Inc.

HOLD

Current Price

$22.53

Market Cap

382.6M

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

N/A

Current Price

$53.36

Market Cap

368.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTGO
MNPR
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.6M
368.9M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
CTGO
MNPR
Price
$22.53
$53.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$41.00
$107.00
AVG Volume (30 Days)
550.9K
162.9K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
19.77
54.99
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.17
$28.40
52 Week High
$34.38
$105.00

Technical Indicators

Market Signals
Indicator
CTGO
MNPR
Relative Strength Index (RSI) 49.80 49.61
Support Level $22.10 $50.77
Resistance Level $26.42 $60.67
Average True Range (ATR) 1.36 2.74
MACD 0.14 -0.09
Stochastic Oscillator 36.19 52.76

Price Performance

Historical Comparison
CTGO
MNPR

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: